Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s
right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Denali Therapeutics (DNLI) hired Katie Peng as chief commercial officer. Previously, she was a senior vice president at Genentech, where she headed the OMNI business unit and was responsible for the neurology, ophthalmology, immunology, respiratory and rare diseases portfolio.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
